摘要
基于RNAi的疗法认为有前景成为anti-gene领域有效的治疗应用策略。然而,尽管它拥有巨大的潜力, 但是其发展面临各种困扰,其全部功能无法实现真正的意义。需要努力推动具体而有效的发展策略来克服临床上至关重要的约束。本文陈述了当前成功将siRNA翻译由概念变成现实的主要障碍以及努力攻克这些难关而正在进行的一些研究。
关键词: 抗基因,有效的,RNAi,安全,治疗
Current Gene Therapy
Title:SiRNA Nanotherapeutics _The Panacea of Diseases?
Volume: 15 Issue: 2
Author(s): Khan Farheen Badrealam, Swaleha Zubair and Mohammad Owais
Affiliation:
关键词: 抗基因,有效的,RNAi,安全,治疗
摘要: RNAi based therapeutics hold s great promises to be an efficient strategy of the anti-gene realm in context of its therapeutic applications; however, despite significant potentials, its full efficacy cannot be realized in real sense owing to various confronts that plague its advancement. Efforts need to be driven for the development of specific and efficacious strategies to subdue some of their crucial constraints towards successes in clinics. This article will present the major impediments that encumber successful translation of siRNA concept into reality and the ongoing research endeavours to get through those stumbling blocks along with their inadequacies.
Export Options
About this article
Cite this article as:
Khan Farheen Badrealam, Swaleha Zubair and Mohammad Owais , SiRNA Nanotherapeutics _The Panacea of Diseases?, Current Gene Therapy 2015; 15 (2) . https://dx.doi.org/10.2174/1566523215666150122130047
DOI https://dx.doi.org/10.2174/1566523215666150122130047 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel and Emerging Drugs for Chronic Lymphocytic Leukemia
Current Cancer Drug Targets Nano Traditional Chinese Medicine: Current Progresses and Future Challenges
Current Drug Targets Design of Lipophilic Prodrugs to Improve Drug Delivery and Efficacy
Current Drug Targets Pharmacogenetics of Therapy in Inflammatory Bowel Disease Patients
Current Pharmacogenomics Animal Venom Peptides: Potential for New Antimicrobial Agents
Current Topics in Medicinal Chemistry Progress in Nutritional and Health Profile of Milk and Dairy Products: A Novel Drug Target
Endocrine, Metabolic & Immune Disorders - Drug Targets Factors Controlling Chromatin Organization and Nucleosome Positioning for Establishment and Maintenance of HIV Latency
Current HIV Research Cancer Stem Cells in Solid and Liquid Tissues of Breast Cancer Patients: Characterization and Therapeutic Perspectives
Current Cancer Drug Targets Proteomics in Acute Myelogenous Leukaemia (AML): Methodological Strategies and Identification of Protein Targets for Novel Antileukaemic Therapy
Current Drug Targets Epigenetic Modifications in Acute Lymphoblastic Leukemia: From Cellular Mechanisms to Therapeutics
Current Gene Therapy Stem Cell Therapies
Recent Patents on Regenerative Medicine Self-Renewal Versus Differentiation in Hematopoietic Stem and Progenitor Cells: A Focus on Asymmetric Cell Divisions
Current Stem Cell Research & Therapy The Role of Capecitabine in the Management of Tumors of the Digestive System
Reviews on Recent Clinical Trials Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies
Current Drug Targets Negative Regulation of NEDD8 Conjugation Pathway by Novel Molecules and Agents for Anticancer Therapy
Current Pharmaceutical Design Targeted – Therapy and Imaging Response: A New Paradigm For Clinical Evaluation?
Reviews on Recent Clinical Trials Antiangiogenic Triterpenes Isolated from Chinese Herbal Medicine Actinidia chinensis Planch
Anti-Cancer Agents in Medicinal Chemistry Dexrazoxane for the Prevention of Cardiac Toxicity and Treatment of Extravasation Injury from the Anthracycline Antibiotics
Current Pharmaceutical Biotechnology Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors
Current Genomics Berberine as a Promising Safe Anti-Cancer Agent- Is there a Role for Mitochondria?
Current Drug Targets